Apply for Copaxone (Glatiramer Acetate) Copay Assistance & Patient Assistance Programs

How does the Copaxone copay card work?

The Copaxone copay card is a manufacturer savings program. It reduces out-of-pocket costs for commercially insured patients with a Copaxone prescription. Eligible patients may pay $0 per month.

The program covers costs up to an annual maximum benefit. QuickRx handles enrollment, tracks your benefits, and manages annual renewals. Your savings continue without interruption.

Who qualifies for Copaxone copay assistance?

Eligibility depends on your insurance type. Different programs serve different patients.

Commercial insurance patients: May qualify for the Copaxone manufacturer copay card. You need active private insurance, a valid glatiramer acetate prescription, US residency, and you must be 18 or older.

Medicare, Medicaid, VA, or TRICARE patients: Cannot use manufacturer copay cards. Federal Anti-Kickback Statute regulations block this. You may qualify for foundation grants instead.

Uninsured patients: May qualify for manufacturer patient assistance programs based on income.

Call (917) 830-2525 to run a complete benefits investigation.

Can I get copay assistance for Glatopa or generic glatiramer acetate?

Yes. Copay assistance is available for FDA-approved generic glatiramer acetate. This includes Glatopa and other generic versions.

Generic copay programs work like brand Copaxone copay cards. Eligible commercially insured patients may pay $0 per month.

Generic glatiramer acetate also costs less than brand Copaxone before any assistance applies. Stacking generic pricing with copay assistance often produces the lowest total cost.

How much does Copaxone cost without insurance?

Brand Copaxone costs approximately $6,500 to $7,000 per month without insurance. Generic glatiramer acetate and Glatopa cost approximately $1,400 to $1,950 per month. Eligible patients may pay $0 per month through copay assistance.

Pricing depends on dose strength, pharmacy, and your location.

Pricing source: Drugs.com and GoodRx, May 2026. Subject to change. QuickRx helps eligible patients pay $0 per month through copay assistance programs.

What if my Copaxone copay card runs out?

Manufacturer copay cards have annual benefit maximums. Patients with high deductibles may exhaust benefits before year-end.

QuickRx has backup strategies:

• Switch to Glatopa or generic glatiramer acetate. Each has a separate annual cap.
• Apply for foundation grants from PAN Foundation, HealthWell Foundation, or The Assistance Fund.
• Enroll in manufacturer patient assistance programs based on financial need.

We monitor copay card usage every month. We secure backup assistance before your benefits run out. Call (917) 830-2525 if you received a depletion notice.

Does Medicare cover Copaxone?

Yes. Medicare Part D plans cover Copaxone, glatiramer acetate, and Glatopa.

Medicare patients cannot use manufacturer copay cards. Federal Anti-Kickback Statute regulations block this. But you have other options:

• Foundation grants from independent nonprofits
• Medicare Extra Help and Low-Income Subsidy programs
• Manufacturer patient assistance based on financial need
• Generic glatiramer acetate or Glatopa, which typically have lower Medicare Part D copays than brand Copaxone

QuickRx patient navigators review your Medicare plan and identify every available option.

How long does Copaxone copay assistance approval take?

Most commercial insurance approvals complete within 24 to 48 hours after submission. QuickRx handles every step: insurance verification, prior authorization, copay card enrollment, and coordination with your prescriber.

Call (917) 830-2525 to start. We work to prevent delays in your MS treatment.

What is the difference between a copay card and a patient assistance program?

A copay card reduces out-of-pocket costs for commercially insured patients. Eligible patients may pay $0 per month. The manufacturer sponsors the program.

A patient assistance program (PAP) provides free or reduced-cost medication. PAPs serve uninsured or underinsured patients who meet income requirements.

Foundation grants are a third option. They serve Medicare and Medicaid patients who cannot use copay cards.

QuickRx checks your eligibility for all three. We enroll you in every program you qualify for at no cost.

Is generic glatiramer acetate as effective as brand Copaxone?

Yes. The FDA requires generic glatiramer acetate to match brand Copaxone in active ingredient, strength, dose form, and route of administration.

The FDA rates Glatopa and generic glatiramer acetate as therapeutically equivalent to brand Copaxone. Most patients can switch between brand and generic safely. Discuss any switch with your neurologist first.

What is the difference between 20 mg/mL and 40 mg/mL Copaxone?

The two strengths are not interchangeable. They follow different dosing schedules.

• 20 mg/mL: Injected once daily under the skin.
• 40 mg/mL: Injected three times per week, at least 48 hours apart.

Your neurologist selects the strength based on your treatment plan. Do not switch between strengths without medical guidance.

How is Copaxone injected and stored?

Copaxone is a subcutaneous injection. You inject it under the skin in the arm, abdomen, hip, or thigh. Rotate injection sites to reduce skin reactions.

Store Copaxone in the refrigerator between 36°F and 46°F. Do not freeze. You can keep unrefrigerated Copaxone at room temperature for up to 30 days. Protect from light.

QuickRx provides injection training and ships Copaxone with proper cold-chain packaging.

What are the common side effects of Copaxone?

Common side effects include:

• Injection site reactions: redness, swelling, itching, or pain
• Flushing
• Chest pain
• Shortness of breath
• Anxiety
• Heart palpitations
• Joint pain
• Herpes simplex infection

Most post-injection reactions resolve within 15 minutes. Contact your neurologist if symptoms persist or worsen.

Seek emergency care for severe reactions, including:

• Anaphylaxis or severe allergic reaction
• Throat tightness or difficulty breathing
• Injection site tissue necrosis
• Signs of liver problems: yellowing of skin or eyes, severe nausea, confusion

This is a partial list. Read the full prescribing information with your medication.

Can I switch between Copaxone, Glatopa, and generic glatiramer acetate?

Yes. All three products contain the same active ingredient at the same strength. The FDA rates Glatopa and generic glatiramer acetate as therapeutically equivalent to brand Copaxone.

Many patients switch to Glatopa or generic glatiramer acetate to access lower costs or different copay programs. Always discuss switches with your neurologist before changing therapy.

What is multiple sclerosis?

Multiple sclerosis (MS) is a chronic autoimmune disease. Your immune system attacks the protective coating around nerve fibers in your brain and spinal cord.

This damage disrupts communication between your brain and body. Common symptoms include fatigue, numbness, vision problems, muscle weakness, and balance issues.

Copaxone, Glatopa, and generic glatiramer acetate are disease-modifying therapies. They reduce relapse frequency and slow disease progression in relapsing forms of MS.

Does QuickRx ship Copaxone to my state?

Yes. QuickRx Specialty Pharmacy ships Copaxone, Glatopa, and generic glatiramer acetate to all 50 states. We are URAC and ACHC accredited. We provide cold-chain packaging to maintain medication integrity during shipping.

Free delivery is included with every prescription.

Does QuickRx charge a fee for Copaxone copay assistance?

No. QuickRx provides free Copaxone copay assistance enrollment. We never charge service fees.

Our team handles insurance verification, prior authorization, copay card applications, patient assistance program enrollment, foundation grant coordination, and annual renewals at no cost. QuickRx has helped patients save over $65 million on copay assistance.

How do I start Copaxone copay assistance with QuickRx?

Three ways to get started:

• Call (917) 830-2525 to speak with a patient navigator
• Fill out the form on this page
• Ask your neurologist to send your prescription to QuickRx Specialty Pharmacy

A QuickRx patient navigator will contact you within 1 business day. We verify your benefits, identify every program you qualify for, and submit applications on your behalf.

1. Copaxone (glatiramer acetate) [prescribing information]. Parsippany, NJ: Teva Neuroscience Inc; January 2025.
2. Glatopa (glatiramer acetate) [prescribing information]. Princeton, NJ: Sandoz Inc; February 2025.
3. U.S. Food and Drug Administration. DailyMed: Copaxone and Glatopa labeling. Available at: dailymed.nlm.nih.gov
4. U.S. Food and Drug Administration. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Available at: FDA.gov Orange Book
5. National Multiple Sclerosis Society. Disease-Modifying Therapies for MS. Available at: nationalmssociety.org
6. National Institute of Neurological Disorders and Stroke. Multiple Sclerosis Information Page. Available at: ninds.nih.gov
7. Rae-Grant A, Day GS, Marrie RA, et al. Practice guideline: disease-modifying therapies for adults with multiple sclerosis. American Academy of Neurology. Neurology. 2018. Available at: aan.com
8. Cohen J, Belova A, Selmaj K, et al. Equivalence of generic glatiramer acetate in multiple sclerosis: a randomized clinical trial. JAMA Neurology. 2015;72(12):1433–1441. doi:10.1001/jamaneurol.2015.2154
9. Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology. 1995;45(7):1268–1276.
10. Centers for Medicare & Medicaid Services. Medicare Part D Prescription Drug Coverage. Available at: cms.gov

Author: Paola Larrabure, Pharma Content Manager
Reviewer: Julia Kravtsova, PharmD, Head Patient Navigator
Last Reviewed: May 2026